The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck Serono; Roche; Sanofi; SERVIER; SERVIER
Exploiting DNA repair alterations in metastatic pancreatic cancer (mPAC): Is MGMT methylation a new therapeutic target?
 
Monica Niger
No Relationships to Disclose
 
Federica Morano
No Relationships to Disclose
 
Sara Manglaviti
No Relationships to Disclose
 
Alessandra Raimondi
No Relationships to Disclose
 
Federica Perrone
No Relationships to Disclose
 
Elena Tamborini
No Relationships to Disclose
 
Matteo Marcuzzo
No Relationships to Disclose
 
Federico Nichetti
No Relationships to Disclose
 
Giorgia Peverelli
No Relationships to Disclose
 
Filippo Pagani
No Relationships to Disclose
 
Giovanni Randon
No Relationships to Disclose
 
Arianna Ottini
No Relationships to Disclose
 
Martina Torchio
No Relationships to Disclose
 
Michele Prisciandaro
No Relationships to Disclose
 
Maria Antista
No Relationships to Disclose
 
Filippo Pietrantonio
No Relationships to Disclose
 
Sara Pusceddu
No Relationships to Disclose
 
Giancarlo Pruneri
Expert Testimony - Roche Molecular Diagnostics
Travel, Accommodations, Expenses - Roche
 
Maria Di Bartolomeo
Consulting or Advisory Role - Lilly; SERVIER
Travel, Accommodations, Expenses - Roche; Servier
 
Filippo G. De Braud
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Daiichi Sankyo; Dompè; Ignyta; Incyte; Novartis; Octimet; Pfizer; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Bristol-Myers Squibb; Menarini; MSD; Novartis; Pfizer; Roche
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Roche